De Novo Drug Design on JNK3+QED alpha=0.2
94Observed Coverage
Unweighted
Updated 1mo ago
Evaluation Results
| Method | Links | |
|---|---|---|
2023.10 | 94 | |
2023.10 | 86 | |
2023.10 | 86 | |
2023.10 | 73 | |
2023.10 | 73 | |
2023.10 | 72 | |
2023.10 | 64 | |
2023.10 | 20 |
Unweighted
| Method | Links | |
|---|---|---|
2023.10 | 94 | |
2023.10 | 86 | |
2023.10 | 86 | |
2023.10 | 73 | |
2023.10 | 73 | |
2023.10 | 72 | |
2023.10 | 64 | |
2023.10 | 20 |